CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study
Status:
Completed
Trial end date:
2016-12-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of J022X ST for prevention of
Recurrent Upper-Respiratory Tract Infections (RURTI) compared to placebo in children of
younger age who develop infectious diseases more frequently than other children of this age
in general.